A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 24
Summary
- Conditions
- Idiopathic Thrombocytopenic Purpura
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01549054
- Collaborators
- Not Provided
- Investigators
- Study Director: Bhaskar Rege Eisai Inc.
Get Well Soon